About
Technology
Issues
FAQ
Search
Profile
Top Authors
Prolific Authors
Top Journals
Main Disciplines
Main Topics
Most Cited Articles
Scientometrics
Avg Impact Factor
★★
Articles
★★★
Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Schools
›
Division of Nuclear Medicine
›
top-articles
Division of Nuclear Medicine
241
(top 1%)
papers
14.7K
(top 1%)
citations
67
(top 1%)
h
-index
116
(top 1%)
g
-index
297
all documents
15.7K
doc citations
2.1K
citing journals
Top Articles
#
Title
Journal
Year
Citations
1
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Brain
2009
596
2
The Role of Parietal Cortex in Verbal Working Memory
Journal of Neuroscience
1998
556
3
The Alzheimer's Disease Neuroimaging Initiative positron emission tomography core
Alzheimer's and Dementia
2010
464
4
Components of verbal working memory: Evidence from neuroimaging
Proceedings of the National Academy of Sciences of the United States of America
1998
442
5
In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease
Annals of Neurology
1996
411
6
History of falls in Parkinson disease is associated with reduced cholinergic activity
Neurology
2009
357
7
In vivo mapping of cerebral acetylcholinesterase activity in aging and Alzheimer’s disease
Neurology
1999
337
8
Compartmental Analysis of [
11
C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography
Journal of Cerebral Blood Flow and Metabolism
1991
322
9
Globally convergent algorithms for maximum a posteriori transmission tomography
IEEE Transactions on Image Processing
1995
273
10
Effects of Buprenorphine Maintenance Dose on μ-Opioid Receptor Availability, Plasma Concentrations, and Antagonist Blockade in Heroin-Dependent Volunteers
Neuropsychopharmacology
2003
264
11
Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease
Brain
2010
263
12
Isolation of Specific Interference Processing in the Stroop Task: PET Activation Studies
NeuroImage
1997
261
13
Categorical and correlational analyses of baseline fluorodeoxyglucose positron emission tomography images from the Alzheimer's Disease Neuroimaging Initiative (ADNI)
NeuroImage
2009
258
14
PET Evidence for an Amodal Verbal Working Memory System
NeuroImage
1996
236
15
Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease
Annals of Neurology
2012
206
16
Cognitive function and nigrostriatal markers in abstinent methamphetamine abusers
Psychopharmacology
2006
204
17
The Alzheimer's Disease Neuroimaging Initiative 2 PET Core: 2015
Alzheimer's and Dementia
2015
199
18
Cholinergic Dysfunction in Parkinson’s Disease
Current Neurology and Neuroscience Reports
2013
193
19
Reducing between scanner differences in multi-center PET studies
NeuroImage
2009
192
20
Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal Study
Journal of Nuclear Medicine
2011
189
21
Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function
Annals of Neurology
1988
175
22
Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography
Annals of Neurology
1988
169
23
Quantifying Interictal Metabolic Activity in Human Temporal Lobe Epilepsy
Journal of Cerebral Blood Flow and Metabolism
1990
169
24
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Journal of Nuclear Medicine
2018
163
25
Spinocerebellar ataxia type 1 with multiple system degeneration and glial cytoplasmic inclusions
Annals of Neurology
1996
160
26
Heterogeneity of Cholinergic Denervation in Parkinson's Disease without Dementia
Journal of Cerebral Blood Flow and Metabolism
2012
154
27
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC
Journal of Nuclear Cardiology
2018
151
28
The effect of graded aversive stimuli on limbic and visual activation
Neuropsychologia
2000
150
29
Carbon-11 hydroxyephedrine with positron emission tomography for serial assessment of cardiac adrenergic neuronal function after acute myocardial infarction in humans
Journal of the American College of Cardiology
1993
138
30
Medial frontal cortex involvement in PTSD symptoms: a spect study
Journal of Psychiatric Research
1999
138
31
Temporal and Spatial Dynamics of Human Forebrain Activity During Heat Pain: Analysis by Positron Emission Tomography
Journal of Neurophysiology
2001
136
32
Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects
Journal of the American College of Cardiology
1994
132
33
Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomography
European Journal of Nuclear Medicine and Molecular Imaging
1994
131
34
3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects
Neurobiology of Aging
2010
127
35
Limbic Activation and Psychophysiologic Responses to Aversive Visual Stimuli Interaction with Cognitive Task
Neuropsychopharmacology
2000
124
36
Improved Power for Characterizing Longitudinal Amyloid-β PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region
Journal of Nuclear Medicine
2015
122
37
Frequency of Cholinergic and Caudate Nucleus Dopaminergic Deficits Across the Predemented Cognitive Spectrum of Parkinson Disease and Evidence of Interaction Effects
JAMA Neurology
2015
121
38
Limited donepezil inhibition of acetylcholinesterase measured with positron emission tomography in living Alzheimer cerebral cortex
Annals of Neurology
2000
118
39
Buprenorphine-Induced Changes in Mu-Opioid Receptor Availability in Male Heroin-Dependent Volunteers A Preliminary Study
Neuropsychopharmacology
2000
116
40
Leucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease
Brain
2011
108
41
Combined PET and low-dose, noncontrast CT scanning obviates the need for additional diagnostic contrast-enhanced CT scans in patients undergoing staging or restaging for lymphoma
Annals of Oncology
2008
106
42
Preablation 131-I Scans With SPECT/CT in Postoperative Thyroid Cancer Patients: What Is the Impact on Staging?
Journal of Clinical Endocrinology and Metabolism
2013
106
43
Kinetic Modeling of N-[11C]Methylpiperidin-4-yl Propionate: Alternatives for Analysis of an Irreversible Positron Emission Tomography Tracer for Measurement of Acetylcholinesterase Activity in Human Brain
Journal of Cerebral Blood Flow and Metabolism
1999
102
44
Extra‐nigral pathological conditions are common in Parkinson's disease with freezing of gait: An
in vivo
positron emission tomography study
Movement Disorders
2014
101
45
In vivo Muscarinic Cholingeric Receptor Imaging in Human Brain with [11C]Scopolamine and Positron Emission Tomography
Journal of Cerebral Blood Flow and Metabolism
1992
100
46
EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy
European Journal of Nuclear Medicine and Molecular Imaging
2019
99
47
Parametric in vivo imaging of benzodiazepine receptor distribution in human brain
Annals of Neurology
1991
98
48
Evaluation of Sympathetic Nerve Terminals With [
11
C]Epinephrine and [
11
C]Hydroxyephedrine and Positron Emission Tomography
Circulation
2000
98
49
The influence of biological and technical factors on quantitative analysis of amyloid PET: Points to consider and recommendations for controlling variability in longitudinal data
Alzheimer's and Dementia
2015
98
50
Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing
Experimental Neurology
2005
97
site/software ©
exaly
; All materials licenced under
CC by-SA
.